These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 Or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
Delaware
|
|
77-0390628
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification Number)
|
|
|
|
|
|
308 Dorla Court, Suite 206
|
|
|
|
Zephyr Cove, Nevada
|
|
89448
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Title of Class
|
|
Name of Exchange on Which Registered
|
|
Common Stock, par value $0.0001 per share
|
|
NYSE MKT LLC
|
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
|
|
|
Page
|
|
|
|
|
|
PART I
|
||
|
|
|
|
|
Item 1.
|
4
|
|
|
Item 1A.
|
14
|
|
|
Item 1B.
|
21
|
|
|
Item 2.
|
21
|
|
|
Item 3.
|
22
|
|
|
Item 4.
|
23
|
|
|
|
|
|
|
PART II
|
||
|
|
|
|
|
Item 5.
|
24
|
|
|
Item 6.
|
25
|
|
|
Item 7.
|
26
|
|
|
Item 7A.
|
35
|
|
|
Item 8.
|
36
|
|
|
Item 9.
|
57
|
|
|
Item 9A.
|
57
|
|
|
Item 9B.
|
57
|
|
|
|
|
|
|
PART III
|
||
|
|
|
|
|
Item 10.
|
58
|
|
|
Item 11.
|
58
|
|
|
Item 12.
|
58
|
|
|
Item 13.
|
58
|
|
|
Item 14.
|
58
|
|
|
|
|
|
|
PART IV
|
||
|
|
|
|
|
Item 15.
|
59
|
|
| · | Automatic and seamless to the user . After a one-time registration, users connect securely on a “zero-click” or “single-click” basis. |
| · | Secure data communications . Users create secure networks with people they trust and communicate over a secure channel. |
| · | Control of data at all times . Users can secure and customize their unified communication and collaboration applications such as file sharing and remote desktop with policy-based access and secure presence information. |
| · | Authenticated users . Users know they are communicating with authenticated users with secure domain names. |
| · | Application-agnostic technology . Our solution provides security at the IP layer of the network by using patented DNS lookup mechanisms to make connections between secure domain names, thereby obviating the need to provide application specific security. |
| · | SECURE CHAT - allows users to quickly send and receive text, files and screen shots |
| · | SECURE SHARE - allows users to grant coworkers read/write access to desired folders |
| · | SECURE VIDEO/VOICE - provides users ability to conduct audio and/or video conferencing securely with any other Gabriel user |
| · | SECURE MAIL - allows users to send email and attachments directly from sender to recipient without requiring a centralized mail server |
| · | SECURE SYNC/BACKUP - allows users to quickly push single files or automatically backup your files to one or multiple Gabriel destinations |
| · | Unique patented technology . We are focused on developing innovative technology for securing real-time communications over the Internet, and establishing the exclusive secure domain name registry in the United States and other key markets around the world. Our unique solutions combine industry standard encryption methods and communication protocols with our patented techniques for automated DNS lookup mechanisms. Our technology and patented approach enables users to create a secure communication link by generating secure domain names. We currently own approximately 39 U.S. and 66 foreign patents with approximately 75 pending patents applications worldwide. Our portfolio includes patents and pending patent applications in the United States and other key markets that support our secure domain name registry service for the Internet. |
| · | Scalable licensing business model . We are actively engaged in pursuing additional licensing agreements with OEMs, service providers and system integrators within the IP-telephony, mobility, mobile-to-mobile communications, fixed-mobile convergence and unified communications end-markets. |
| · | Highly experienced research and development team . Our research and development team is comprised of nationally recognized network security and encryption technology scientists and experts that have worked together as a team for over ten years. During their careers, this team has developed several cutting-edge technologies for U.S. national defense, intelligence and civilian agencies, many of which remain critical to our national security today. Prior to joining VirnetX, our team worked for Leidos, during which time they invented the technology that is the foundation of our technology, and software. Based on the collective knowledge and experience of our development team, we believe that we have one of the most experienced and sophisticated groups of security experts researching vulnerability and threats to real-time communication over the Internet and developing solutions to mitigate these problems. |
| · | Introduce our Gabriel Secure Communication Platform™ and Gabriel Collaboration Suite™ products in the general market in the first-half of 2015 for sale directly to end-user enterprises. |
| · | Continue to grow our technology licensing program to commercialize our intellectual property, including our GABRIEL Connection Technology™ by adding more licensees. |
| · | Establish VirnetX as the exclusive universal registry of secure domain names and to enable our customers to act as registrars for their users and broker secure communication between users on different registries. |
| · | VirnetX technology licensing : Customers who want to develop their own implementation of the VirnetX code module for supporting secure domain names, or who want to use their own techniques that are covered by our patent portfolio for establishing secure communication links, will purchase a technology license. We anticipate that these licenses would typically include an initial license fee, as well as an ongoing royalty. We expect that these licenses will include a one-time delivery of GABRIEL software development kit including object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement of the techniques we have developed. |
| · | GABRIEL Connection Technology™ Software Development Kit or SDK : OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution for establishing secure connections using secure domain names within their products will purchase an SDK license. The software development kit consists of object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement our technology. These tools are comprised of software for a secure domain name connection test server, a relay test server and a registration test server. We expect that customers would pay an up-front license fee to purchase an SDK license and a royalty fee for every product shipped with the embedded VirnetX code module. |
| · | Secure domain name registrar service : Customers, including service providers, telecommunication companies, ISPs, system integrators and OEMs could purchase a license to our secure domain name registrar service. We would provide the software suite and technology support to enable such customers to provision devices with secure domain names and facilitate secure connections between registered devices. This suite includes the following server software modules: |
| · | Registrar server software : We anticipate that our registrar server software would enable customers to operate as a secure domain name registrar that provisions devices with secure domain names. The registrar server software is designed to provide an interface for our customers to register new virtual private domains and sub-domain names. This server module must be enrolled with the VirnetX secure domain name master registry to obtain its credentials before functioning as an authorized registrar. |
| · | Connection server software : We anticipate that our connection server software would allow customers to provide connection services to enrolled devices. The connection services include registration of presence information for authenticated users and devices, presence information query request services, enforcement of policies and support for communication with peers behind firewalls. |
| · | Relay server software : We anticipate that our relay server software would allow customers to dynamically maintain connections and relay data to private IP addresses for network devices that reside behind firewalls. Secure domain name registrar service customers will enter into a technology licensing and revenue sharing agreement with VirnetX whereby we will typically receive an up-front licensing fee for the secure domain name registrar technology, as well as ongoing annual royalties for each secure domain name issued by the customer. |
| · | Secure domain name master registry and connection service : As part of enabling the secure domain name registrar service, we expect that we will maintain and manage the secure domain name master registry. This service is expected to enroll all secure domain name registrar customers and generate the credentials required to function as an authorized registrar. It also is expected to provide connection services and universal name resolution, presence information and secure connections between authorized devices with secure domain names. |
| · | Technical support services : We intend to provide high-quality technical support services to licensees and customers for the rapid customization and deployment of GABRIEL Connection Technology™ in an individual customer’s products and services. |
| · | Proprietary or home-grown application specific security solutions have been developed by vendors and integrated directly into their products for our target markets including IP-telephony, mobility, fixed-mobile convergence, and unified communications. These proprietary solutions have been developed due to the lack of standardized approaches to securing real-time communications. This approach has led to corporate networks that are isolated and, as a result, restrict enterprises to using these next-generation networks within the boundaries of their private network. These solutions generally do not provide security for communications over the Internet or require network administrators to manually exchange keys and other security parameters with each destination network outside their corporate network boundary. The cost-savings and other benefits of IP-based real-time communications are significantly limited by this approach to securing real-time communications. |
| · | A session border controller, or SBC, is a device used in networks to exert control over the signaling and media streams involved in establishing, conducting and terminating VoIP calls. A traditional firewall or network address translation, or NAT, device typically block information like endpoint IP addresses and port numbers required by signaling protocols, such as SIP and XMPP, to reach and communicate with their intended destination. SBCs are used in physical networks to address these limitations and enable real-time session traffic to cross the boundaries created by firewalls and other NAT devices and enable VoIP calls to be established successfully. However, SBCs must decrypt and analyze every single data packet for the information to be transmitted successfully, thereby preventing end-to-end encryption. This network design results in SBCs becoming a single point of congestion on the network, as well as a single point of failure. SBCs are also limited to the physical network they secure. |
| · | SIP firewalls, or SIP-aware firewalls, and application layer gateways, manage and protect the traffic, flow and quality of VoIP and other SIP-related communications. They perform real-time network address translation, dynamic firewall functions; support multiple signaling protocols, and media functionality, allowing secure interconnection and the flow of IP media streams across multiple networks. While SIP firewalls assist in analyzing SIP traffic transmitted over the corporate network to filter out various threats, they do not necessarily encrypt the traffic. As a result, this traffic is not entirely secure from end-to-end nor is it protected against threats like man-in-middle and eavesdropping. |
| · | Although we have to date entered into a limited number of settlement and license agreements, we may not be successful in entering into further licensing relationships and existing settlement and license agreements may not generate the financial results we expect; |
| · | Third parties may challenge the validity of our patents; |
| · | The pendency of our various litigations may cause potential licensees not to do business with us; |
| · | We expect that we will face intense competition new and established competitors who may have superior products and services or better marketing, financial or other capacities than we do; and |
| · | It is possible that one or more of our potential customers or licensees develops or otherwise sources products or technologies similar to, competitive with or superior to ours. |
| · | New legislation, regulations, court and agency decisions, or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue. For instance, the U.S. Supreme Court has recently modified some tests used by the United States Patent and Trademark Office (USPTO) in granting patents during the past 20 years which may decrease the likelihood that we will be able to obtain patents and increase the likelihood of challenge of any patents we obtain or license. In addition, the Leahy-Smith America Act (“AIA”) has implemented sweeping changes to the United States patent system including changes that transition the United States from a “first-to-invent” system to a “first to file” system and alter the processes for challenging issued patents |
| · | More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO. |
| · | Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer. |
| · | The need to educate potential customers about our patent rights and our product and service capabilities; |
| · | Customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products; |
| · | Even if successful there can be no assurance that our technologies will be used in a product that is ultimately brought to market, achieves commercial acceptance or results in significant royalties to us; |
| · | Customers’ budgetary constraints; |
| · | The timing of customers’ budget cycles; and |
| · | Delays caused by customers’ internal review processes. |
| · | power loss, transmission cable cuts and other telecommunications failures; |
| · | damage or interruption caused by fire, earthquake, and other natural disasters |
| · | computer viruses or software defects; and |
| · | physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control |
| · | developments in any then-outstanding litigation; |
| · | quarterly variations in our operating results; |
| · | large purchases or sales of common stock or derivatives transactions related to our stock; |
| · | actual or anticipated announcements of new products or services by us or competitors; |
| · | general conditions in the markets in which we compete; and |
| · | economic and financial conditions |
| · | the outcome of actions to enforce our intellectual property rights currently in progress or that we may undertake in the future, and the timing thereof; |
| · | the amount and timing of receipt of license fees from potential infringers, licensees or customers; |
| · | the rate of adoption of our patented technologies; |
| · | the number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations, expiration date etc.; |
| · | the success of a licensee in selling products that use our patented technologies; and |
| · | the amount and timing of expenses related to our patent filings and enforcement proceedings, including litigation, related to our intellectual property rights |
| · | A staggered Board of Directors : This means that only one or two directors (since we have a five-person Board of Directors) will be up for election at any given annual meeting. This has the effect of delaying the ability of stockholders to effect a change in control of us because it would take two annual meetings to effectively replace a majority of the Board of Directors. |
| · | Blank check preferred stock : Our Board of Directors has the authority to establish the rights, preferences and privileges of our 10,000,000 authorized, but unissued, shares of preferred stock. Therefore, this stock may be issued at the discretion of our Board of Directors with preferences over your shares of our common stock in a manner that is materially dilutive to you. In addition, blank check preferred stock can be used to create a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of Directors. We have not adopted such a “poison pill;” but our Board of Directors has the ability to do so in the future, very rapidly and without stockholder approval. |
| · | Advance notice requirements for director nominations and for new business to be brought up at stockholder meetings : Stockholders wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows and in very specific form in order to have the matter voted on at a stockholder meeting. This has the effect of giving our Board of Directors and management more time to react to stockholder proposals generally and could also have the effect of disregarding a stockholder proposal or deferring it to a subsequent meeting to the extent such proposal is not raised properly. |
| · | No stockholder actions by written consent : No stockholder or group of stockholders may take actions rapidly and without prior notice to our Board of Directors and management or to the minority stockholders. Along with the advance notice requirements described above, this provision also gives our Board of Directors and management more time to react to proposed stockholder actions. |
| · | Super majority requirement for stockholder amendments to the By-laws : Stockholder proposals to alter or amend our By-laws or to adopt new By-laws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock. |
| · | No ability of stockholders to call a special meeting of the stockholders : Only the Board of Directors or management can call special meetings of the stockholders. This could mean that stockholders, even those who represent a significant percentage of our shares of common stock, may need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders. |
| Item 5. | Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. |
|
Quarter Ended
|
High
|
Low
|
||||||
|
3/31/13
|
$
|
36.84
|
$
|
17.98
|
||||
|
6/30/13
|
$
|
26.25
|
$
|
16.10
|
||||
|
9/30/13
|
$
|
22.41
|
$
|
16.70
|
||||
|
12/31/13
|
$
|
23.20
|
$
|
17.16
|
||||
|
3/31/14
|
$
|
25.49
|
$
|
12.68
|
||||
|
6/30/14
|
$
|
18.57
|
$
|
12.10
|
||||
|
9/30/14
|
$
|
18.24
|
$
|
4.18
|
||||
|
12/31/14
|
$
|
6.85
|
$
|
3.80
|
||||
|
|
12/09
|
12/10
|
12/11
|
12/12
|
12/13
|
12/14
|
|||||||||||||||||||
|
|
|||||||||||||||||||||||||
|
VirnetX Holding Corp
|
100.00
|
547.55
|
920.69
|
1079.61
|
715.68
|
202.43
|
|||||||||||||||||||
|
S&P 500
|
100.00
|
115.06
|
117.49
|
136.30
|
180.44
|
205.14
|
|||||||||||||||||||
|
RDG Technology Composite
|
100.00
|
111.01
|
110.85
|
126.07
|
167.16
|
193.22
|
|
|
For the year ended December 31,
|
|||||||||||||||||||
|
|
2014
|
2013
|
2012
|
2011
|
2010
|
|||||||||||||||
|
Consolidated Statement of Operations Data:
|
|
|
|
|
|
|||||||||||||||
|
Revenue
|
$
|
1,249
|
$ |
2,197
|
$
|
412
|
$
|
20
|
$
|
68
|
||||||||||
|
Gain on settlement
|
$
|
23,000
|
$ |
—
|
—
|
—
|
$
|
200,000
|
||||||||||||
|
Other operating expenses
|
$
|
(36,414
|
)
|
$
|
(30,784
|
)
|
$
|
(39,273
|
)
|
$
|
(17,396
|
)
|
$
|
(95,383
|
)
|
|||||
|
Income tax (expense) benefit
|
$
|
(15
|
)
|
$
|
(751
|
)
|
$
|
12,535
|
$
|
5,480
|
$
|
(34,062
|
)
|
|||||||
|
Net (loss) income
|
$
|
(9,902
|
)
|
$
|
(27,608
|
)
|
$
|
(26,924
|
)
|
$
|
(17,263
|
)
|
$
|
41,417
|
||||||
|
Earnings (loss) per share
|
$
|
(0.19
|
)
|
$
|
(0.54
|
)
|
$
|
(0.53
|
)
|
$
|
(0.35
|
)
|
$
|
0.91
|
||||||
|
Dividends declared per common share
|
$
|
0.00
|
$
|
0.00
|
$
|
0.00
|
$
|
0.00
|
$
|
0.50
|
||||||||||
|
Consolidated Balance Sheet Data:
|
|
|||||||||||||||||||
|
Cash and cash equivalents
|
$
|
18,658
|
$
|
19,173
|
$
|
19,661
|
$
|
49,482
|
$
|
34,635
|
||||||||||
|
Investments available for sale
|
$
|
22,571
|
$
|
19,815
|
$
|
26,493
|
$
|
14,438
|
$
|
43,457
|
||||||||||
|
Total assets
|
$
|
45,090
|
$
|
39,398
|
$
|
61,313
|
$
|
74,633
|
$
|
81,694
|
||||||||||
|
Long-term obligation
|
—
|
—
|
—
|
—
|
---
|
|||||||||||||||
|
Stockholders’ equity (deficit)
|
$
|
32,627
|
$
|
34,024
|
$
|
53,944
|
$
|
68,277
|
$
|
59,453
|
||||||||||
| · | Consideration for Past Sales : Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured. |
| · | Current Royalty Payments : Ongoing royalty payments cover a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited. |
| · | Non-Refundable Up-Front Fees and Minimum Fee Contracts : For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term. For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but generally not in advance of collection. |
| · | Non-Royalty Elements : Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations. |
|
2014
|
2013
|
|||||||
|
Deferred Revenue, beginning of year
|
$
|
667
|
$
|
-
|
||||
|
Payment received
|
2,500
|
2,500
|
||||||
|
Less: Amount amortized as revenue
|
1,167
|
1,833
|
||||||
|
Deferred Revenue, end of year
|
$
|
2,000
|
$
|
667
|
||||
|
|
2014
|
2013
|
2012
|
|||||||||
|
|
||||||||||||
|
Revenue
|
$
|
1,249
|
$
|
2,197
|
$
|
412
|
||||||
|
|
2014
|
2013
|
2012
|
|||||||||
|
|
||||||||||||
|
Research and Development
|
$
|
2,004
|
$
|
1,782
|
$
|
1,555
|
||||||
|
|
2014
|
2013
|
2012
|
|||||||||
|
|
||||||||||||
|
Selling, General and Administrative
|
$
|
28,310
|
$
|
29,002
|
$
|
37,718
|
||||||
|
2014
|
2013
|
2012
|
||||||||||
|
Gain on Settlement
|
$
|
(23,000
|
)
|
$
|
—
|
$
|
—
|
|||||
|
|
2014
|
2013
|
2012
|
|||||||||
|
|
||||||||||||
|
Other Income and Expense
|
$
|
2,238
|
$
|
1,608
|
$
|
(927
|
)
|
|||||
|
Year Ended December 31, 2014
|
Year Ended December 31, 2013
|
Year Ended December 31, 2012
|
||||||||||
|
United States federal statutory rate
|
35.00
|
%
|
35.00
|
%
|
35.00
|
%
|
||||||
|
State taxes, net of federal benefit
|
(0.02
|
)%
|
(1.48
|
)%
|
1.07
|
%
|
||||||
|
Valuation allowance
|
(41.67
|
)%
|
(37.11
|
)%
|
(4.41
|
)%
|
||||||
|
Stock options
|
0.39
|
%
|
(0.17
|
)%
|
0.14
|
%
|
||||||
|
Prior year adjustment
|
( 0.13
|
)%
|
( 1.32
|
)%
|
1.03
|
%
|
||||||
|
Warrants
|
7.92
|
%
|
2.10
|
%
|
(0.82
|
)%
|
||||||
|
Other
|
(1.64
|
)%
|
0.18
|
%
|
(0.32
|
)%
|
||||||
|
Effective income tax rate
|
(0.15
|
)%
|
(2.80
|
)%
|
31.69
|
%
|
||||||
|
|
Total
|
2015
|
There after
|
|||||||||
|
|
|
|
|
|||||||||
|
Leases
|
46
|
46
|
—
|
|||||||||
|
Total
|
$
|
46
|
$
|
46
|
—
|
|||||||
|
|
Page
|
|
Report of Farber Hass Hurley LLP, Independent Registered Public Accounting Firm
|
37
|
|
Consolidated Balance Sheets of VirnetX Holding Corporation as of December 31, 2014 and December 31, 2013
|
38
|
|
Consolidated Statements of Operations of VirnetX Holding Corporation for the years ended December 31, 2014, December 31, 2013 and December 31, 2012
|
39
|
|
Consolidated Statements of Comprehensive Loss of VirnetX Holding Corporation for the years ended December 31, 2014, December 31, 2013 and December 31, 2012
|
39
|
|
Consolidated Statements of Stockholders’ Equity of VirnetX Holding Corporation for the years ended December 31, 2014, December 31, 2013 and December 31, 2012
|
40
|
|
Consolidated Statements of Cash Flows of VirnetX Holding Corporation for the years ended December 31, 2014, December 31, 2013 and December 31, 2012
|
41
|
|
Notes to Financial Statements of VirnetX Holding Corporation
|
42
|
|
|
/s/
Farber Hass Hurley LLP
|
|
|
|
|
Chatsworth, California
|
|
|
March 2, 2015
|
|
|
|
As of
December 31, 2014
|
As of
December 31, 2013
|
||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
18,658
|
$
|
19,173
|
||||
|
Investments available for sale
|
22,571
|
19,815
|
||||||
|
Prepaid expenses - current
|
653
|
357
|
||||||
|
Total current assets
|
41,882
|
39,345
|
||||||
|
Prepaid expenses – non-current
|
3,144
|
—
|
||||||
|
Property and equipment, net
|
64
|
53
|
||||||
|
Total assets
|
$
|
45,090
|
$
|
39,398
|
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued liabilities
|
$
|
3,554
|
$
|
1,748
|
||||
|
Royalty payable
|
6,100
|
—
|
||||||
|
Related-party payable
|
81
|
—
|
||||||
|
Income tax liability
|
408
|
395
|
||||||
|
Deferred revenue, current portion
|
1,500
|
667
|
||||||
|
Derivative liability
|
320
|
2,564
|
||||||
|
Total current liabilities
|
11,963
|
5,374
|
||||||
|
Deferred revenue, non-current portion
|
500
|
—
|
||||||
|
Commitments and contingencies (Note 5)
|
—
|
—
|
||||||
|
Stockholders' equity:
|
||||||||
|
Preferred stock, par value $0.0001 per share
|
||||||||
|
Authorized: 10,000,000 shares at December 31, 2014 and 2013,
|
||||||||
|
Issued and outstanding: 0 shares at December 31, 2014 and 2013
|
—
|
—
|
||||||
|
Common stock, par value $0.0001 per share
|
||||||||
|
Authorized: 100,000,000 shares at December 31, 2014 and 2013, Issued and outstanding: 51,996,701 shares and 51,236,141 shares, at December 31, 2014 and 2013, respectively
|
5
|
5
|
||||||
|
Additional paid-in capital
|
133,072
|
124,589
|
||||||
|
Accumulated deficit
|
(100,435
|
)
|
(90,533
|
)
|
||||
|
Accumulated other comprehensive loss
|
(15
|
)
|
(37
|
)
|
||||
|
Total stockholders' equity
|
32,627
|
34,024
|
||||||
|
Total liabilities and stockholders' equity
|
$
|
45,090
|
$
|
39,398
|
||||
|
|
Year Ended
December 31,
2014
|
Year Ended
December 31,
2013
|
Year Ended
December 31,
2012
|
|||||||||
|
Revenue
|
$
|
1,249
|
$
|
2,197
|
$
|
412
|
||||||
|
Operating expenses:
|
||||||||||||
|
Royalty expense
|
6,100
|
—
|
—
|
|||||||||
|
Research and development
|
2,004
|
1,782
|
1,555
|
|||||||||
|
General, selling and administrative
|
28,310
|
29,002
|
37,718
|
|||||||||
|
Gain on settlement (Note 3)
|
(23,000
|
)
|
—
|
—
|
||||||||
|
Total operating expenses
|
13,414
|
30,784
|
39,273
|
|||||||||
|
Loss from operations
|
(12,165
|
)
|
(28,587
|
)
|
(38,861
|
)
|
||||||
|
Gain (loss) on change in value of embedded derivative and warrants
|
2,238
|
1,608
|
(927
|
)
|
||||||||
|
Interest income, net
|
40
|
122
|
329
|
|||||||||
|
Loss before taxes
|
(9,887
|
)
|
(26,857
|
)
|
(39,459
|
)
|
||||||
|
Income tax (expense) benefit
|
(15
|
)
|
(751
|
)
|
12,535
|
|||||||
|
Net loss
|
$
|
(9,902
|
)
|
$
|
(27,608
|
)
|
$
|
(26,924
|
)
|
|||
|
Basic and diluted loss per share:
|
$
|
(0.19
|
)
|
$
|
(0.54
|
)
|
$
|
(0.53
|
)
|
|||
|
Weighted average shares outstanding basic and diluted
|
51,570,472
|
51,188,006
|
50,934,266
|
|||||||||
|
|
Year Ended
December 31,
2014
|
Year Ended
December 31,
2013
|
Year Ended
December 31,
2012
|
|||||||||
|
Net loss
|
$
|
(9,902
|
)
|
$
|
(27,608
|
)
|
$
|
(26,924
|
)
|
|||
|
Other comprehensive income (loss), net of tax:
|
||||||||||||
|
Change in equity adjustment from foreign currency translation, net of tax
|
—
|
(12
|
)
|
—
|
||||||||
|
Change in unrealized gain (loss) on investments, net of tax
|
22
|
(33
|
)
|
12
|
||||||||
|
Total other comprehensive income (loss), net of tax
|
22
|
(45
|
)
|
12
|
||||||||
|
Comprehensive loss
|
$
|
(9,880
|
)
|
$
|
(27,653
|
)
|
$
|
(26,912
|
)
|
|||
|
|
Common Stock
|
Additional Paid-in
|
Accumulated
|
Other Comprehensive Income
|
Total Stockholders' Equity
|
|||||||||||||||||||
|
|
Shares
|
Amount
|
Capital
|
Deficit
|
(Expense)
|
(Deficit)
|
||||||||||||||||||
|
Balance at December 31, 2011
|
50,619,136
|
$
|
5
|
$
|
104,277
|
$
|
(36,001
|
)
|
$
|
(4
|
)
|
$
|
68,277
|
|||||||||||
|
|
||||||||||||||||||||||||
|
Stock issued for cash exercise of warrants at $3.93-3.59 per share, net
|
44,941
|
161
|
161
|
|||||||||||||||||||||
|
Stock-based compensation
|
6,162
|
6,162
|
||||||||||||||||||||||
|
Deferred tax benefit related to stock based compensation
|
3,111
|
3,111
|
||||||||||||||||||||||
|
Derivative liability
|
1,454
|
1,454
|
||||||||||||||||||||||
|
Exercise of options
|
486,165
|
1,691
|
1,691
|
|||||||||||||||||||||
|
Comprehensive income:
|
||||||||||||||||||||||||
|
Net loss
|
(26,924
|
)
|
(26,924
|
)
|
||||||||||||||||||||
|
Other comprehensive income net of tax
|
12
|
12
|
||||||||||||||||||||||
|
Comprehensive loss
|
(26,912
|
)
|
||||||||||||||||||||||
|
Balance at December 31, 2012
|
51,150,242
|
$
|
5
|
$
|
116,856
|
$
|
(62,925
|
)
|
$
|
8
|
$
|
53,944
|
||||||||||||
|
|
||||||||||||||||||||||||
|
Stock-based compensation
|
7,563
|
7,563
|
||||||||||||||||||||||
|
Exercise of options
|
39,833
|
170
|
170
|
|||||||||||||||||||||
|
Vested RSUs
|
46,066
|
|||||||||||||||||||||||
|
Comprehensive income:
|
||||||||||||||||||||||||
|
Net loss
|
(27,608
|
)
|
(27,608
|
)
|
||||||||||||||||||||
|
Other comprehensive income net of tax
|
(45
|
)
|
(45
|
)
|
||||||||||||||||||||
|
Comprehensive loss
|
(27,653
|
)
|
||||||||||||||||||||||
|
Balance at December 31, 2013
|
51,236,141
|
$
|
5
|
$
|
124,589
|
$
|
(90,533
|
)
|
$
|
(37
|
)
|
$
|
34,024
|
|||||||||||
|
Stock issued for cash exercise of warrants at 3.59 per share, net
|
2,500
|
9
|
9
|
|||||||||||||||||||||
|
Stock-based compensation
|
8,189
|
8,189
|
||||||||||||||||||||||
|
Exercise of options
|
679,321
|
278
|
278
|
|||||||||||||||||||||
|
Vested RSUs
|
78,739
|
|||||||||||||||||||||||
|
Derivative liability
|
7
|
7
|
||||||||||||||||||||||
|
Comprehensive income:
|
||||||||||||||||||||||||
|
Net loss
|
(9,902
|
)
|
(9,902
|
)
|
||||||||||||||||||||
|
Other comprehensive income net of tax
|
22
|
22
|
||||||||||||||||||||||
|
Comprehensive loss
|
(9,880
|
)
|
||||||||||||||||||||||
|
Balance at December 31, 2014
|
51,996,701
|
$
|
5
|
$
|
133,072
|
$
|
(100,435
|
)
|
$
|
(15
|
)
|
$
|
32,627
|
|||||||||||
|
|
Year Ended
December 31,
2014
|
Year Ended
December 31,
2013
|
Year Ended
December 31,
2012
|
|||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net (loss)
|
$
|
(9,902
|
)
|
$
|
(27,608
|
)
|
$
|
(26,924
|
)
|
|||
|
Adjustments to reconcile net (loss) to net cash used in operating activities:
|
||||||||||||
|
Depreciation and amortization
|
25
|
36
|
71
|
|||||||||
|
Stock-based compensation
|
8,189
|
7,563
|
6,162
|
|||||||||
|
Net change in deferred taxes
|
—
|
—
|
3,158
|
|||||||||
|
Change in value of derivative liability
|
(2,238
|
)
|
(1,608
|
)
|
927
|
|||||||
|
Changes in assets and liabilities:
|
||||||||||||
|
Prepaid expenses and other current assets
|
(296
|
)
|
(243
|
)
|
(23
|
)
|
||||||
|
Prepaid expenses – Non-current
|
(3,144
|
)
|
—
|
—
|
||||||||
|
Prepaid taxes
|
—
|
14,963
|
(4,934
|
)
|
||||||||
|
Deferred revenue
|
1,333
|
667
|
—
|
|||||||||
|
Accounts payable and accrued liabilities
|
1,806
|
(1,449
|
)
|
1,970
|
||||||||
|
Royalty payable
|
6,100
|
—
|
—
|
|||||||||
|
Related-party payable
|
81
|
—
|
—
|
|||||||||
|
Income tax liability
|
13
|
395
|
—
|
|||||||||
|
Net cash provided by (used in) operating activities
|
1,967
|
(7,284
|
)
|
(19,593
|
)
|
|||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Purchase of property and equipment
|
(35
|
)
|
(7
|
)
|
(37
|
)
|
||||||
|
Purchase of investments
|
(45,500
|
)
|
(92,729
|
)
|
(59,342
|
)
|
||||||
|
Proceeds from sale, maturity of investments
|
42,766
|
99,362
|
47,299
|
|||||||||
|
Net cash provided by (used in) investing activities
|
(2,769
|
)
|
6,626
|
(12,080
|
)
|
|||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Proceeds from exercise of options
|
278
|
170
|
1,691
|
|||||||||
|
Proceeds from exercise of warrants
|
9
|
—
|
161
|
|||||||||
|
Net cash provided by financing activities
|
287
|
170
|
1,852
|
|||||||||
|
Net decrease in cash and cash equivalents
|
(515
|
)
|
(488
|
)
|
(29,821
|
)
|
||||||
|
Cash and cash equivalents, beginning of year
|
19,173
|
19,661
|
49,482
|
|||||||||
|
Cash and cash equivalents, end of year
|
$
|
18,658
|
$
|
19,173
|
$
|
19,661
|
||||||
|
Supplemental disclosure of cash flow information:
|
||||||||||||
|
Cash paid during the year for taxes
|
$
|
2
|
$
|
—
|
$
|
—
|
||||||
|
Cash paid during the year for interest
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
|
·
|
Consideration for Past Sales
: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.
|
|
·
|
Current Royalty Payments
: Ongoing royalty payments cover a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.
|
|
·
|
Non-Refundable Up-Front Fees and Minimum Fee Contracts
: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term. For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but generally not in advance of collection.
|
|
·
|
Non-Royalty Elements
: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.
|
|
2014
|
2013
|
|||||||
|
Deferred Revenue, beginning of year
|
$
|
667
|
$
|
-
|
||||
|
Payment received
|
2,500
|
2,500
|
||||||
|
Less: Amount amortized as revenue
|
1,167
|
1,833
|
||||||
|
Deferred Revenue, end of year
|
$
|
2,000
|
$
|
667
|
||||
|
|
December 31
|
|||||||||||
|
|
2014
|
2013
|
2012
|
|||||||||
|
Office furniture
|
$
|
70
|
$
|
70
|
$
|
70
|
||||||
|
Computer equipment
|
157
|
121
|
115
|
|||||||||
|
Total
|
227
|
191
|
185
|
|||||||||
|
Less accumulated depreciation
|
(163
|
)
|
(138
|
)
|
(115
|
)
|
||||||
|
|
$
|
64
|
$
|
53
|
$
|
70
|
||||||
|
Options Outstanding
|
Options Vested and Exercisable
|
|||||||||||||||||||||||||||
|
Date of
Option Issue
|
Range of
Exercise Prices
|
Number
Outstanding
|
Weighted
Average
Remaining
Contractual Life (Years)
|
Weighted Average
Exercise Price
|
Number
Exercisable
|
Weighted
Average
Remaining
Contractual Life (Years)
|
Weighted
Average
Exercise
Price
|
|||||||||||||||||||||
|
2006
|
$
|
0.24
|
41,516
|
1.22
|
$
|
0.24
|
41,516
|
1.22
|
$
|
0.24
|
||||||||||||||||||
|
2007
|
$
|
4.20
|
1,277,574
|
2.56
|
4.20
|
1,277,574
|
2.56
|
4.20
|
||||||||||||||||||||
|
2007
|
$
|
5.88-6.47
|
563,931
|
2.99
|
5.88
|
563,931
|
2.99
|
5.88
|
||||||||||||||||||||
|
2008
|
$
|
1.74-6.20
|
129,500
|
3.40
|
5.00
|
129,500
|
3.40
|
5.00
|
||||||||||||||||||||
|
2009
|
$
|
1.15- 1.58
|
922,986
|
4.26
|
1.16
|
922,986
|
4.26
|
1.16
|
||||||||||||||||||||
|
2010
|
$
|
5.48-6.03
|
259,896
|
5.17
|
5.49
|
259,896
|
5.17
|
5.49
|
||||||||||||||||||||
|
2011
|
$
|
19.85-23.62
|
405,000
|
6.37
|
23.62
|
367,499
|
6.37
|
23.62
|
||||||||||||||||||||
|
2012
|
$
|
23.84 – 35.25
|
357,500
|
7.40
|
27.03
|
242,083
|
7.38
|
27.03
|
||||||||||||||||||||
|
2013
|
$
|
23.72 – 35.05
|
269,625
|
8.37
|
25.40
|
128,717
|
8.37
|
25.41
|
||||||||||||||||||||
|
2014
|
$
|
14.52-15.40
|
261,500
|
9.50
|
15.21
|
41,928
|
9.46
|
14.97
|
||||||||||||||||||||
|
|
4,489,028
|
4.61
|
$
|
9.33
|
3,975,630
|
4.11
|
$
|
7.79
|
||||||||||||||||||||
|
|
Options
|
|||||||||||||||
|
|
Number of
Shares
|
Weighted Average
Exercise Price
|
Weighted Average
Remaining Contractual
Life (Years)
|
Aggregate Intrinsic
Value
|
||||||||||||
|
Outstanding at December 31, 2011
|
4,906,998
|
$
|
5.12
|
—
|
—
|
|||||||||||
|
Options granted
|
367,500
|
26.97
|
—
|
—
|
||||||||||||
|
Options exercised
|
(486,165
|
)
|
3.48
|
—
|
—
|
|||||||||||
|
Options cancelled
|
(12,109
|
)
|
17.34
|
—
|
—
|
|||||||||||
|
Outstanding at December 31, 2012
|
4,776,224
|
6.94
|
—
|
—
|
||||||||||||
|
Options granted
|
274,625
|
25.37
|
—
|
—
|
||||||||||||
|
Options exercised
|
(39,833
|
)
|
4.27
|
—
|
—
|
|||||||||||
|
Options cancelled
|
(34,167
|
)
|
20.57
|
—
|
—
|
|||||||||||
|
Outstanding at December 31, 2013
|
4,976,849
|
7.86
|
—
|
—
|
||||||||||||
|
Options granted
|
261,500
|
15.21
|
—
|
—
|
||||||||||||
|
Options exercised
|
(679,321
|
)
|
0.41
|
—
|
—
|
|||||||||||
|
Options cancelled
|
(70,000
|
)
|
13.38
|
—
|
—
|
|||||||||||
|
Outstanding at December 31, 2014
|
4,489,028
|
$
|
9.33
|
4.61
|
$
|
6,000
|
||||||||||
|
|
RSUs
|
|||||||||||
|
|
Number of
RSUs
|
Weighted Average
Grant Date
Fair Value
|
Aggregate Intrinsic
Value
|
|||||||||
|
Outstanding at December 31, 2011
|
—
|
—
|
—
|
|||||||||
|
RSUs granted
|
151,665
|
25.60
|
—
|
|||||||||
|
Outstanding at December 31, 2012
|
151,665
|
$
|
25.60
|
$
|
—
|
|||||||
|
RSUs granted
|
156,415
|
23.72
|
—
|
|||||||||
|
RSUs vested
|
(55,832
|
)
|
27.06
|
—
|
||||||||
|
RSUs cancelled
|
(3,333
|
)
|
24.75
|
—
|
||||||||
|
Outstanding at December 31, 2013
|
248,915
|
$
|
24.10
|
$
|
—
|
|||||||
|
RSUs granted
|
154,332
|
15.30
|
—
|
|||||||||
|
RSUs vested
|
(88,686
|
)
|
24.08
|
—
|
||||||||
|
RSUs cancelled
|
(4,167
|
)
|
24.13
|
—
|
||||||||
|
Outstanding at December 31, 2014
|
310,394
|
$
|
19.74
|
$
|
—
|
|||||||
|
Stock-Based Compensation by Type of Award
|
Year Ended
December 31, 2014
|
Year Ended
December 31, 2013
|
Year Ended
December 31, 2012
|
|||||||||
|
Employee stock options
|
$
|
5,951
|
$
|
6,488
|
$
|
5,171
|
||||||
|
RSUs
|
2,238
|
1,075
|
991
|
|||||||||
|
Total stock-based compensation expense
|
$
|
8,189
|
$
|
7,563
|
$
|
6,162
|
||||||
|
|
Year Ended
December 31,
2014
|
Year Ended
December 31,
2013
|
Year Ended
December 31,
2012
|
|||||||||
|
Expected stock price volatility
|
88
|
%
|
93
|
%
|
111
|
%
|
||||||
|
Risk-free interest rate
|
2.56
|
%
|
2.04
|
%
|
1.90
|
%
|
||||||
|
Expected life term (in years)
|
6.0 years
|
6.10 years
|
6.8 years
|
|||||||||
|
Expected dividends
|
0
|
%
|
0
|
%
|
0
|
%
|
||||||
|
|
Year Ended December 31,
|
|||||||||||
|
|
2014
|
2013
|
2012
|
|||||||||
|
Net loss
|
$
|
(9,902
|
)
|
$
|
(27,608
|
)
|
$
|
(26,924
|
)
|
|||
|
Basic weighted average number of shares outstanding
|
51,570
|
51,188
|
50,934
|
|||||||||
|
Diluted weighted average number of shares outstanding
|
51,570
|
51,188
|
50,934
|
|||||||||
|
Basic and diluted loss per share
|
$
|
(0.19
|
)
|
$
|
(0.54
|
)
|
$
|
(0.53
|
)
|
|||
|
Original
Number of
Warrants
Issued
|
Exercise
Price per
Common
Share
|
Exercisable at
December 31,
2013
|
Became
Exercisable
|
Exercised
|
Terminated /
Cancelled /
Expired
|
Exercisable at
December 31,
2013
|
Expiration
Date
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| 2,619,036 | (1) |
$
|
3.59
|
159,967
|
—
|
2,500
|
—
|
157,467
|
March 2015
|
|||||||||||||||||
|
Total
|
159,967
|
—
|
2,500
|
—
|
157,467
|
|
||||||||||||||||||||
|
(1)
|
Referred to as our Series I Warrants.
|
|
|
Year Ended
December 31,
2014
|
Year Ended
December 31,
2013
|
Year Ended
December 31,
2012
|
|||||||||
|
Current:
|
|
|
|
|||||||||
|
Federal
|
$
|
(13
|
)
|
$
|
(354
|
)
|
$
|
12,154
|
||||
|
State
|
(2
|
)
|
(397
|
)
|
428
|
|||||||
|
Foreign
|
-
|
-
|
-
|
|||||||||
|
|
(15
|
)
|
(751
|
)
|
12,582
|
|||||||
|
Deferred:
|
||||||||||||
|
Federal
|
-
|
-
|
(40
|
)
|
||||||||
|
State
|
-
|
-
|
(7
|
)
|
||||||||
|
|
-
|
-
|
(47
|
)
|
||||||||
|
Total (provision) benefit for income taxes
|
$
|
(15
|
)
|
$
|
(751
|
)
|
$
|
12,535
|
||||
|
|
Year Ended
December 31,
2014
|
Year Ended
December 31,
2013
|
Year Ended
December 31,
2012
|
|||||||||
|
|
|
|
|
|||||||||
|
United States federal statutory rate
|
35.00
|
%
|
35.00
|
%
|
35.00
|
%
|
||||||
|
State taxes, net of federal benefit
|
(0.02
|
)%
|
(1.48
|
)%
|
1.07
|
%
|
||||||
|
Valuation allowance
|
(41.67
|
)%
|
(37.11
|
)%
|
(4.41
|
)%
|
||||||
|
Stock options
|
0.39
|
%
|
(0.17
|
)%
|
0.14
|
%
|
||||||
|
Prior year true-up
|
(0.13
|
)%
|
(1.32
|
)%
|
1.03
|
%
|
||||||
|
Warrants
|
7.92
|
%
|
2.10
|
%
|
(0.82
|
)%
|
||||||
|
Other
|
(1.64
|
)%
|
0.18
|
%
|
(0.32
|
)%
|
||||||
|
Effective income tax rate
|
(0.15
|
)%
|
(2.80
|
)%
|
31.69
|
%
|
||||||
|
|
Year Ended
December 31,
2014
|
Year Ended
December 31,
2013
|
||||||
|
Deferred tax assets:
|
|
|
||||||
|
Reserves and accruals
|
$
|
-
|
$
|
58
|
||||
|
State tax
|
1
|
1
|
||||||
|
Research and development credits and other credits
|
924
|
907
|
||||||
|
Net operating loss carry forward
|
11,190
|
8,249
|
||||||
|
Stock based compensation
|
8,452
|
6,600
|
||||||
|
Other
|
127
|
154
|
||||||
|
Total deferred tax assets
|
20,694
|
15,969
|
||||||
|
|
||||||||
|
Valuation allowance
|
(20,679
|
)
|
(15,955
|
)
|
||||
|
Deferred tax assets after valuation allowance
|
15
|
14
|
||||||
|
|
||||||||
|
Deferred tax liability:
|
||||||||
|
Depreciation and amortization
|
(15
|
)
|
(14
|
)
|
||||
|
|
||||||||
|
Total deferred tax liability
|
(15
|
)
|
(14
|
)
|
||||
|
|
||||||||
|
Net deferred tax assets
|
$
|
-
|
$
|
-
|
||||
|
|
Year Ended
December 31,
2014
|
Year Ended
December 31,
2013
|
Year Ended
December 31,
2012
|
|||||||||
|
|
|
|
|
|||||||||
|
Balance at the beginning of the year
|
$
|
316
|
$
|
128
|
$
|
128
|
||||||
|
Additions based on tax positions related to the current year
|
-
|
-
|
-
|
|||||||||
|
Additions for tax positions of prior years
|
-
|
188
|
-
|
|||||||||
|
Settlements
|
-
|
-
|
-
|
|||||||||
|
Lapse of applicable statute of limitations
|
-
|
-
|
-
|
|||||||||
|
Balance at the end of the year
|
$
|
316
|
$
|
316
|
$
|
128
|
||||||
|
|
December 31, 2014
|
|||||||||||||||||||||||
|
|
Adjusted
Cost
|
Unrealized
Gains
|
Unrealized
Losses
|
Fair
Value
|
Cash
and Cash
Equivalents
|
Investments
Available
for Sale
|
||||||||||||||||||
|
Cash
|
$
|
1,183
|
$
|
-
|
$
|
-
|
$
|
1,183
|
$
|
1,183
|
$
|
-
|
||||||||||||
|
|
||||||||||||||||||||||||
|
Level 1:
|
||||||||||||||||||||||||
|
Mutual funds
|
10,139
|
-
|
-
|
10,139
|
10,139
|
-
|
||||||||||||||||||
|
Corporate securities
|
9,405
|
1
|
(3
|
)
|
9,403
|
1,645
|
7,758
|
|||||||||||||||||
|
U.S agency securities
|
20,504
|
2
|
(2
|
)
|
20,504
|
5,691
|
14,813
|
|||||||||||||||||
|
|
40,048
|
3
|
(5
|
)
|
40,046
|
17,475
|
22,571
|
|||||||||||||||||
|
Total
|
$
|
41,231
|
$
|
3
|
$
|
(5
|
)
|
$
|
41,229
|
$
|
18,658
|
$
|
22,571
|
|||||||||||
|
|
December 31, 2013
|
|||||||||||||||||||||||
|
|
Adjusted
Cost
|
Unrealized
Gains
|
Unrealized
Losses
|
Fair
Value
|
Cash
and Cash
Equivalents
|
Investments
Available
for Sale
|
||||||||||||||||||
|
Cash
|
$
|
11,699
|
$
|
-
|
$
|
-
|
$
|
11,699
|
$
|
11,699
|
$
|
-
|
||||||||||||
|
|
||||||||||||||||||||||||
|
Level 1:
|
||||||||||||||||||||||||
|
Mutual funds
|
73
|
-
|
-
|
73
|
73
|
-
|
||||||||||||||||||
|
Corporate securities
|
10,782
|
-
|
-
|
10,782
|
2,325
|
8,457
|
||||||||||||||||||
|
Municipal securities
|
2,172
|
-
|
-
|
2,172
|
665
|
1,507
|
||||||||||||||||||
|
U.S agency securities
|
14,287
|
-
|
(25
|
)
|
14,262
|
4,411
|
9,851
|
|||||||||||||||||
|
|
27,314
|
-
|
(25
|
)
|
27,289
|
7,474
|
19,815
|
|||||||||||||||||
|
Total
|
$
|
39,013
|
$
|
-
|
$
|
(25
|
)
|
$
|
38,988
|
$
|
19,173
|
$
|
19,815
|
|||||||||||
|
|
Quoted
Prices in
Active
Markets for
Identical
Assets
|
Significant
Other
Observable
Inputs
|
Significant
Unobservable
Inputs
|
|||||||||||||
|
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
Total
|
||||||||||||
|
Series l Warrants
|
$
|
—
|
$
|
—
|
$
|
320
|
$
|
320
|
||||||||
|
Total
|
$
|
—
|
$
|
—
|
$
|
320
|
$
|
320
|
||||||||
|
|
Quoted
Prices in
Active
Markets for
Identical
Assets
|
Significant
Other
Observable
Inputs
|
Significant
Unobservable
Inputs
|
|||||||||||||
|
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
Total
|
||||||||||||
|
Series l Warrants
|
$
|
—
|
$
|
—
|
$
|
2,564
|
$
|
2,564
|
||||||||
|
Total
|
$
|
—
|
$
|
—
|
$
|
2,564
|
$
|
2,564
|
||||||||
|
|
Fair Value Measurements Using Significant
Unobservable Inputs (Level 3)
|
|||||||||||
|
|
Year ended
December 31,
2014
|
Year ended
December 31,
2013
|
Year ended
December 31,
2012
|
|||||||||
|
Beginning Balance
|
$
|
2,564
|
$
|
4,172
|
$
|
4,699
|
||||||
|
(Gain) losses included in net losses
|
(2,237
|
)
|
(1,608
|
)
|
927
|
|||||||
|
Settlements
|
(7
|
)
|
—
|
(1,454
|
)
|
|||||||
|
Ending Balance
|
$
|
320
|
$
|
2,564
|
$
|
4,172
|
||||||
|
|
First
|
Second
|
Third
|
Fourth
|
||||||||||||
|
|
(in thousands except per share)
|
|||||||||||||||
|
2014
|
|
|
|
|
||||||||||||
|
Revenue
|
$
|
250
|
$
|
268
|
$
|
292
|
$
|
439
|
||||||||
|
Gain on settlement
|
—
|
—
|
—
|
23,000
|
||||||||||||
|
Income (loss) from operations
|
(6,953
|
)
|
(6,171
|
)
|
(6,250
|
)
|
6,870
|
|||||||||
|
Net Income/ (loss)
|
(6,087
|
)
|
(6,670
|
)
|
(4,468
|
)
|
7,325
|
|||||||||
|
Basic earnings (loss) per common share
|
$
|
(0.12
|
)
|
$
|
(0.13
|
)
|
$
|
(0.09
|
)
|
$
|
0.14
|
|||||
|
Diluted earnings (loss) per common share
|
$
|
(0.12
|
)
|
$
|
(0.13
|
)
|
$
|
(0.09
|
)
|
$
|
0.14
|
|||||
|
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
|
||||||||
|
|
(in thousands except per share)
|
|
||||||||||||||
|
2013
|
|
|
|
|
|
|
|
|
||||||||
|
Revenue
|
|
$
|
293
|
|
|
$
|
6
|
|
|
$
|
1,612
|
|
|
$
|
286
|
|
|
Loss from operations
|
|
|
(9,529
|
)
|
|
|
(6,578
|
)
|
|
|
(5,133
|
)
|
|
|
(7,347
|
)
|
|
Net loss
|
|
|
(7,891
|
)
|
|
|
(7,029
|
)
|
|
|
(5,134
|
)
|
|
|
(7,554
|
)
|
|
Basic and diluted loss per common share
|
|
$
|
(0.15
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
(0.15
|
)
|
|
Securi
ty Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
.
|
|
Plan Category
|
Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options,
Warrants and
Rights
|
Weighted-Average
Exercise Price of
Outstanding
Options, Warrants
and Rights
|
Number of
Securities
Remaining
Available for
Future Issuance
Under Equity
Compensation
Plans
|
|||||||||
|
Equity compensation plans approved by security holders
|
4,964,389
|
$
|
9.81
|
1,886,217
|
||||||||
|
Equity compensation plans not approved by security holders
|
—
|
—
|
||||||||||
|
Total
|
4,964,389
|
$
|
9.81
|
1,886,217
|
||||||||
|
(a)
|
The following documents are filed as part of this Annual Report on Form
|
|
(1)
|
Financial Statements
: See the Index to Consolidated Financial Statements under Item 8 of this Annual Report on Form 10-K.
|
|
(2)
|
Financial Statement Schedule
: Financial statement schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto. All other schedules are omitted because of the absence of conditions under which they are required or because the required information is given in the financial statements or the notes thereto.
|
|
(3)
|
Exhibits
: See Exhibit Index immediately following the signature page of this Form 10-K.
|
|
|
VirnetX Holding Corporation
|
|
|
|
|
|
|
|
By:
|
/s/ Kendall Larsen
|
|
|
|
Name: Kendall Larsen
|
|
|
|
Title: Chief Executive Officer and President
|
|
Name
|
|
Capacity
|
|
Date
|
|
|
|
|
|
|
|
/s/ Kendall Larsen
|
|
Director, Chief Executive Officer and President
|
|
March 2, 2015
|
|
Kendall Larsen
|
|
(
Principal Executive Officer
)
|
|
|
|
|
|
|
|
|
|
/s/ Richard H. Nance
|
|
Chief Financial Officer
|
|
March 2, 2015
|
|
Richard H. Nance
|
|
(
Principal Financial Officer and
Principal Accounting Officer
)
|
|
|
|
|
|
|
|
|
|
/s/ Robert D. Short III
|
|
Director
|
|
March 2, 2015
|
|
Robert D. Short III
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Gary Feiner
|
|
Director
|
|
March 2, 2015
|
|
Gary Feiner
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Michael F. Angelo
|
|
Director
|
|
March 2, 2015
|
|
Michael F. Angelo
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Thomas M. O'Brien
|
|
Director
|
|
March 2, 2015
|
|
Thomas M. O'Brien
|
|
|
|
|
| Exhibit |
Incorporated by reference herein
|
||||
|
Number
|
Description
|
Form
|
Exhibit No.
|
Filing Date
|
File No.
|
|
3.1
|
Certificate of Incorporation of the Company.
|
8-K
|
3.1
|
11/01/2007
|
000-26895
|
|
3.2
|
By-Laws of the Company.
|
8-K
|
3.2
|
11/01/2007
|
000-26895
|
|
4.1
|
Form of Warrant Agency Agreement by and between the Company and Corporate Stock Transfer, Inc. as Warrant Agent.
|
S-1/A
|
4.1
|
01/16/2009
|
333-153645
|
|
4.2
|
Form of Series I Warrant.
|
8-K
|
4.1
|
09/03/2009
|
001-33852
|
|
10.1
|
Form of Indemnification Agreement by and between the Company and each of Kendall Larsen, Robert D. Short III, Gary Feiner, Michael F. Angelo, Thomas M. O'Brien and Richard Nance.
|
8-K
|
10.3
|
07/12/2007
|
000-26895
|
|
10.2*
|
2007 Stock Plan, as amended on April 13, 2012.
|
10-Q
|
10.2
|
05/10/2012
|
001-33852
|
|
10.3*
|
Amended Form of Stock Option Agreement – 2007 Stock Plan.
|
10-Q
|
4.5
|
05/10/2011
|
001-33852
|
|
10.4*
|
Form of Restricted Stock Unit Award Agreement – 2007 Stock Plan.
|
10-Q
|
10.3
|
05/10/2012
|
001-33852
|
|
10.5*
|
2013 Equity Incentive Plan.
|
DEF 14A
|
Appendix A
|
04/12/2013
|
001-33852
|
|
Form of Stock Option Agreement – 2013 Equity Incentive Plan.
|
|||||
|
Form of Restricted Stock Unit Agreement – 2013 Equity Incentive Plan.
|
|||||
|
10.8
|
Voting Agreement among the Company and certain of its stockholders, dated as of December 12, 2007.
|
10-K
|
10.11
|
03/31/2008
|
001-33852
|
|
10.9
|
Securities Purchase Agreement, dated as of September 2, 2009, by and between the Company and the Purchasers (as defined therein).
|
8-K
|
10.1
|
09/03/2009
|
001-33852
|
|
10.10
|
Form of Registration Rights Agreement by and between the Company and the Purchasers (as defined therein).
|
8-K
|
10.2
|
09/03/2009
|
001-33852
|
|
10.11
|
Form of Underwriting Agreement between VirnetX Holding Corporation and Gilford Securities Incorporated.
|
S-1/A
|
1.1
|
01/16/2009
|
333-153645
|
|
10.12
|
Patent License and Assignment Agreement by and between the Company and Leidos, Inc. (formerly Science Applications International Corporation) dated as of August 12, 2005.
|
8-K
|
10.4
|
07/12/2007
|
000-26895
|
|
10.13
|
Amendment No. 1 to Patent License and Assignment Agreement by and between the Company and Leidos, Inc. dated as of November 2, 2006.
|
8-K
|
10.6
|
07/12/2007
|
000-26895
|
|
10.14
|
Amendment No. 2 to Patent License and Assignment Agreement by and between VirnetX, Inc. and Leidos, Inc. dated as of March 12, 2008.
|
8-K
|
10.1
|
03/18/2008
|
001-33852
|
|
10.15
|
Security Agreement by and between the Company and Leidos, Inc. dated as of August 12, 2005.
|
8-K
|
10.5
|
07/12/2007
|
000-26895
|
|
10.16
|
Assignment Agreement between the Company and Leidos, Inc. dated as of December 21, 2006.
|
8-K
|
10.7
|
07/12/2007
|
000-26895
|
|
10.17
|
Professional Services Agreement by and between the Company and Leidos, Inc. dated as of August 12, 2005.
|
8-K
|
10.8
|
07/12/2007
|
000-26895
|
|
10.18
|
IP Brokerage Agreement by and between ipCapital Group, Inc. and VirnetX, Inc., effective as of March 13, 2008.
|
8-K
|
10.2
|
03/18/2008
|
001-33852
|
|
10.19
|
Engagement Letter by and between VirnetX Holding Corporation and ipCapital Group, Inc. dated March 12, 2008.
|
8-K
|
10.3
|
03/18/2008
|
001-33852
|
| Exhibit |
Incorporated by reference herein
|
||||
| Number |
Description
|
Form
|
Exhibit No.
|
Filing Date
|
File No.
|
|
10.20**
|
Engagement Letter dated June 8, 2009, by and between McKool Smith, a professional corporation, and VirnetX, Inc.
|
10-Q
|
10.1
|
08/10/2009
|
001-33852
|
|
10.21**
|
Engagement Letter dated April 15, 2010, by and between McKool Smith, a professional corporation, and VirnetX, Inc.
|
10-Q
|
10.1
|
05/07/2010
|
001-33852
|
|
10.22**
|
Settlement and License Agreement, by and between Microsoft Corporation and VirnetX, Inc., dated May 14, 2010.
|
10-Q/A
|
10.1
|
01/31/2011
|
000-33852
|
|
Amended Settlement and License Agreement, by and between Microsoft Corporation and VirnetX, Inc., dated December 17, 2014.
|
|||||
|
10.24*
|
Employment Offer Letter from VirnetX, Inc. to Richard H. Nance.
|
10-Q
|
10.4
|
05/10/2012
|
001-33852
|
|
Subsidiaries of VirnetX Holding Corporation.
|
|||||
|
Consent of Farber Hass Hurley LLP, Independent Registered Public Accounting Firm.
|
|||||
|
Chief Executive Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act.
|
|||||
|
Chief Financial Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act.
|
|||||
|
Chief Executive Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|||||
|
Chief Financial Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|||||
|
101.INS††
|
XBRL Instance Document
|
||||
|
101.SCH††
|
XBRL Taxonomy Extension Schema Document
|
||||
|
101.CAL††
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
||||
|
101.DEF††
|
XBRL Taxonomy Extension Definition Linkbase Document
|
||||
|
101.LAB††
|
XBRL Taxonomy Extension Label Linkbase Document
|
||||
|
101.PRE††
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|